Factors related to microalbuminuria in patients with chronic obstructive pulmonary disease

Advances in Clinical and Experimental Medicine

Volumn 23, Issue 5, 2014, Pages 749-755

  Kaysoydu, Erdal ^a   Arslan, Sulhattin ^a   Yildiz, Gürsel ^b   Candan, Ferhan ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b Ataturk State Hospital   (Turkey)

Author keywords

Arterial blood gas; COPD; Inflammation; Microalbuminuria; Non dipper

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; ARTERIAL GAS; ARTICLE; BLOOD PRESSURE MONITORING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART RATE; HUMAN; INFLAMMATION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICROALBUMINURIA; PULSE PRESSURE; PULSE RATE; SPIROMETRY; SYSTOLIC BLOOD PRESSURE; URINARY ALBUMIN CREATININE RATIO;

EID: 84930908944     PISSN: 18995276     EISSN: 24512680     Source Type: Journal    
DOI: 10.17219/acem/37236     Document Type: Article

References (33)

1. The Global Strategy for Diagnosis, Management and Prevention of COPD (updated 2013), the Pocket Guide (updated 2013). Available at: http://www.goldcopd.org.
2. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD: The nature of small airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350, 2645-2653.
3. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG: Creactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007, 175, 250-255.
4. de Torres JP, Cordoba-Lanus E, López-Aguilar C, Muros de Fuentes M, Montejo de Garcini A, Aguirre-Jaime A, Celli BR, Casanova C: C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006, 27,902-907.
5. Sin DD, Anthonisen NR, Soriano JB, Agusti AG: Mortality in COPD: role of comorbidities. Eur Respir J 2006, 28, 1245-1257.
6. Diercks GF, Van Boven AJ, Hillege JL, de Jong PE, Rouleau JL, van Gilst WH: The importance of microalbuminuria as a cardiovascular risk indicator: a review. Can J Cardiol 2002, 18, 525-535.
7. Barr RG, Mesia-Vela S, Austin JH, Basner RC, Keller BM, Reeves AP, Shimbo D, Stevenson L: Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med 2007,15,176, 1200-1207.
8. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y: Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients. Hypertension 2005, 45,198-202.
9. Komurcuoglu A, Kalenci S, Kalenci D, Komurcuoglu B, Tibet G: Microalbuminuria in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 2003, 59, 269-272.
10. Cogo A, Ciaccia A, Legorini C, Grimaldi A, Milani G: Proteinuria in COPD patients with and without respiratory failure. Chest 2003,123, 652-653.
11. Polatli M, Cakir A, Cildag O, Bolaman AZ, Yenisey C, Yenicerioglu Y: Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation. J Thromb Thrombolysis 2008, 26, 97-102.
12. Seo WS, Oh HS: The circadian rhythms of blood pressure and heart rate in the hypertensive subjects: dippers and non-dippers. Yonsei Med J 2002,43, 320-328.
13. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, Inenaga T, Kimura G: Orcadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 1999, 33, 29-35.
14. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, Kato J, Kikuchi N, Nishiyama A, Aihara A, Sekino M, Satoh H, Hisamichi S: Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens 1997, 10, 1201-1207.
15. Fagard RH, Van Den Broeke C, De Cort P: Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005,19, 801-807.
16. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y: Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006, 47,149-154.
17. Equiluz-Bruck S, Schnack C, Kopp HP, Scherntaner G: Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus. Am J Hypertens 1996, 9,1139-1143.
18. Inaba M, Negishi K, Takahashi M, Serizawa N, Maruno Y, Takahashi K, Katayama S: Increased night:day blood pressure ratio in microalbuminuric normotensive NIDDM patients. Diabetes Res Clin Pract 1998, 40, 161-166.
19. Agusti AG: COPD, a multicomponent disease: implications for management. Respir Med 2005, 99, 670-682.
20. Casanova C, de Torres JP, Navarro J, Aguirre-Jaime A, Toledo P, Cordoba E, Baz R, Celli BR: Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182, 1004-1010.
21. Stuveling EM, Bakker SJ, Hillege HL, Burgerhof JG, de Jong PE, Gans RO, de Zeeuw D; PREVENU Study Group: C reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension 2004, 43, 791-796.
22. Phelps DT, Ferro TJ, Higgins PJ, Shankar R, Parker DM, Johnson A: TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995, 269, 551-559.
23. Forsblom CM, Groop PH, Ekstrand A, Tötterman KJ, Sane T, Saloranta C, Groop L: Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care 1998, 21,1932-1938.
24. Thoenes M, Reil JC, Khan BV, Bramlage P, Volpe M, Kirch W, Böhm M: Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vase Health Risk Manag 2009, 5, 577-585.
25. Lieb W, Mayer B, Stritzke J, Doering A, Hense HW, Loewel H, Erdmann J, Schunkert H: Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: the MONICA/KORA Augsburg Echocardiographic Substudy. Nephrol Dial Transplant 2006, 21, 2780-2787.
26. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, Benjamin EJ, D'Agostino RB, Vasan RS: Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005, 112, 969-975.
27. Stewart AG, Bardsley PA, Baudouin SV, Waterhouse JC, Thompson JS, Morice AH, Howard P: Changes in atrial natriuretic peptide concentrations during intravenous saline infusion in hypoxic cor pulmonale. Thorax 1991,46, 829-834.
28. Peinado VI, Pizarro S, Barbera JA: Pulmonary vascular involvement in COPD. Chest 2008, 134, 808-814.
29. Stamm AM, Meinerz G, Silva JC: Systemic hypertension and microalbuminuria. Arq Bras Cardiol 2007, 89, 415-420.
30. Deferrari G, Pontremoli R: Microalbuminuria, hypertension and cardiovascular risk. Cardiologia 1994,39,159-162.
31. Farasat SM, Valdes C, Shetty V, Muller DC, Egan JM, Metter EJ, Ferrucci L, Najjar SS: Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure? Hypertension 2010, 55,415-421.
32. Wang Y, Hu Y, Li Y, Li H, Chu S, Zhu D, Gao P: Association of renal function with the ambulatory arterial stiffness index and pulse pressure in hypertensive patients. Hypertens Res 2012, 35, 201-206.
33. Kozan O, Ozcan EE, Sancaktar O, Kabakci G: The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients. Arch Turk Soc Cardiol 2011, 39, 635-645.